Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Challenges and Opportunities for CPS Technologies Corporation

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, CPS Technologies Corporation disclosed a drop in their Q4 EPS results compared to the previous year. This led to a 4.5% decrease in their stock price.

Despite being recognized for their innovative materials manufacturing business, with products even on the international space station, CPS Technologies is encountering obstacles due to their small size, limited profitability, and high valuation in relation to their revenue.

The company recently landed a defense contract to supply armor panels to the U.S. Navy, which caused a significant surge in their market capitalization. However, this sudden increase has raised concerns about CPS Technologies’ overall valuation and profitability moving forward.

CPS Technologies Corporation (CPSH) Stock Price Plummets 21.23% on March 7, 2024: What Investors Need to Know

On March 7, 2024, CPS Technologies Corporation (CPSH) experienced a significant drop in its stock price, closing at $1.99. This marked a decrease of $0.53, or 21.23%, from the previous market close. Despite the steep decline during regular trading hours, CPSH saw a slight uptick of $0.02 in after-hours trading. It is important for investors to closely monitor the stock’s performance and any relevant news or developments that may impact its price movement. Factors such as market trends, company announcements, and industry news can all influence the direction of CPSH’s stock price.

CPSH Stock Performance: Revenue Up, Net Income Down – March 7, 2024 Update

On March 7, 2024, CPSH stock experienced mixed performances based on the latest financial data released by the company. The total revenue for CPSH stood at $26.59 million for the past year, showing an 18.43% increase compared to the previous year. However, the total revenue for the third quarter of the year was $6.29 million, indicating a 15.27% decrease compared to the previous quarter.

The net income for CPSH was reported at $2.13 million for the past year, which represented a 33.72% decrease compared to the previous year. The net income for the third quarter of the year was $171.08 thousand, showing a significant 71.51% decrease compared to the previous quarter.

Furthermore, the earnings per share (EPS) for CPSH were $0.15 for the past year, reflecting a 34.12% decrease compared to the previous year. The EPS for the third quarter of the year was $0.01, indicating a substantial 71.53% decrease compared to the previous quarter.

Overall, the financial performance of CPSH on March 7, 2024, showed a mixed picture. Investors and analysts will closely monitor future financial reports from CPSH to assess the company’s performance and outlook in the market.

Tags: CPSH
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Pharmaceutical Market Capitalization

MindMeds MM120 Program Receives FDA Breakthrough Therapy Designation and Shows Promising Results

Fitness and app

Pelotons CFO Optimistic About Financial Outlook and Shift to Positive Cash Flow

Finances-and-tech

Analyzing Recent Options Trading Trends in Target Stock

Recommended

Fiserv Stock

Fiserv Shares Struggle to Gain Traction Amid Investor Doubts

3 weeks ago
Cooper-Standard Stock

Cooper-Standard Shares Plunge on Disappointing Earnings Report

3 months ago
Volatus Aerospace Stock

Volatus Aerospace Expands Defense and Environmental Technology Operations

5 months ago
FCBC stock news

Symmetry Partners LLC Acquires Significant Position in Carnival Co. & plc, Expresses Optimism for Future Growth

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Trending

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

by Rodolfo Hanigan
February 7, 2026
0

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday,...

Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com